AKBA
|
Akebia Therapeutics, Inc.
|
US
|
NASDAQ
|
AMPE
|
Ampio Pharmaceuticals, Inc.
|
US
|
AMEX
|
ARDX
|
Ardelyx, Inc.
|
US
|
NASDAQ
|
AZN
|
Astrazeneca PLC
|
US
|
NASDAQ
|
BAX
|
Baxter International Inc.
|
US
|
NYSE
|
CALT
|
Calliditas Therapeutics AB
|
US
|
NASDAQ
|
CCXI
|
ChemoCentryx, Inc.
|
US
|
NASDAQ
|
CNCE
|
Concert Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
CTSO
|
Cytosorbents Corporation
|
US
|
NASDAQ
|
CYCN
|
Cyclerion Therapeutics, Inc.
|
US
|
NASDAQ
|
DMAC
|
DiaMedica Therapeutics Inc.
|
US
|
NASDAQ
|
FGEN
|
FibroGen, Inc
|
US
|
NASDAQ
|
ICU
|
SeaStar Medical Holding Corporation
|
US
|
NASDAQ
|
KDNY
|
Chinook Therapeutics, Inc.
|
US
|
NASDAQ
|
LGND
|
Ligand Pharmaceuticals Incorporated
|
US
|
NASDAQ
|
OPK
|
OPKO Health Inc.
|
US
|
NASDAQ
|
PIRS
|
Pieris Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
PROK
|
ProKidney Corp.
|
US
|
NASDAQ
|
RMTI
|
Rockwell Medical, Inc.
|
US
|
NASDAQ
|
RNLX
|
Renalytix AI plc
|
US
|
NASDAQ
|